M
Margaret Rosenfeld
Researcher at University of Washington
Publications - 238
Citations - 17581
Margaret Rosenfeld is an academic researcher from University of Washington. The author has contributed to research in topics: Cystic fibrosis & Medicine. The author has an hindex of 62, co-authored 203 publications receiving 14096 citations. Previous affiliations of Margaret Rosenfeld include Centers for Disease Control and Prevention & Seattle Children's.
Papers
More filters
Journal ArticleDOI
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.
Brian L. Graham,Irene Steenbruggen,Martin R. Miller,Igor Barjaktarevic,Brendan G Cooper,Graham L. Hall,Teal S. Hallstrand,David A. Kaminsky,Kevin McCarthy,Meredith C. McCormack,Cristine E Oropez,Margaret Rosenfeld,Sanja Stanojevic,Maureen P. Swanney,Bruce Thompson +14 more
TL;DR: Standards and consensus recommendations are presented for manufacturers, clinicians, operators, and researchers with the aims of increasing the accuracy, precision, and quality of spirometric measurements and improving the patient experience.
Journal ArticleDOI
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
Julia Emerson,Julia Emerson,Margaret Rosenfeld,Margaret Rosenfeld,Sharon McNamara,Bonnie W. Ramsey,Bonnie W. Ramsey,Ronald L. Gibson,Ronald L. Gibson +8 more
TL;DR: A registry‐based study to determine prognostic indicators of 8‐year mortality and morbidity in young children with cystic fibrosis (CF) and clinical outcomes in 1998 is conducted.
Journal ArticleDOI
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
Jane L. Burns,Ronald L. Gibson,Sharon McNamara,Darlene Yim,Julia Emerson,Margaret Rosenfeld,Peter Hiatt,Karen McCoy,Robert G. Castile,Arnold L. Smith,Bonnie W. Ramsey +10 more
TL;DR: Genotypic and phenotypic changes in P. aeruginosa from oropharynx and bronchoalveolar lavage fluid in a cohort of 40 CF patients during the first 3 years of life suggest infection occurs early in CF and may be intermittent or undetectable by culture.
Journal ArticleDOI
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
Philip M. Farrell,Terry B. White,Clement L. Ren,Sarah E. Hempstead,Frank J. Accurso,Nico Derichs,Michelle S. Howenstine,Susanna A. McColley,Michael J. Rock,Margaret Rosenfeld,Isabelle Sermet-Gaudelus,Kevin W Southern,Bruce C. Marshall,Patrick R. Sosnay +13 more
TL;DR: In this article, a consensus committee of 32 experts in CF diagnosis from 9 countries to develop clear and actionable consensus guidelines on the diagnosis of CF and to clarify diagnostic criteria and terminology for other disorders associated with CFTR mutations.
Journal ArticleDOI
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
Don B. Sanders,Rachel C. L. Bittner,Margaret Rosenfeld,Lucas R. Hoffman,Gregory J. Redding,Christopher H. Goss +5 more
TL;DR: The proportion of patients treated for a pulmonary exacerbation that does not recover to spirometric baseline was determined, allowing clinicians to identify patients who may benefit from closer monitoring and more aggressive treatment.